Hamet Watt, the co-founder of MoviePass, is turning the page after the company’s notable collapse as he embarks on a new entrepreneurial journey with his venture studio, Share Ventures. Established to develop and fund startups, Share Ventures has successfully raised nearly $20 million in funding, with prominent support from tech giants like Alphabet and Amazon.
Watt has expressed a keen focus on innovations in the areas of work and longevity. He believes that the current landscape, characterized by the AI surge and elevated interest rates, presents an opportunity to foster a distinct model in venture capital. Rather than relying on large funding rounds, Share Ventures aims to leverage advanced technology, including its own software and language models, to streamline operations and identify promising opportunities early on.
He points out that many venture firms are investing in innovative technologies but aren’t fully utilizing them in their own processes. Watt emphasizes that applying novel data and automation distinguishes Share Ventures from others in the industry.
Driven by personal experience, Watt’s interest in health and longevity was shaped by the loss of his mother at a young age, inspiring him to look at mortality and life’s potential with new perspective. His previous experience with MoviePass, which has been detailed in a documentary titled “MoviePass, MovieCrash,” serves as a reminder of the lessons learned through failure. He now embraces the challenge of innovating again, ready to explore new ideas, whether they lead to success or not.
Watt’s new venture could potentially lead to significant advancements in the startup ecosystem, particularly in health technology, which is gaining importance as society increasingly focuses on wellness and longevity. His story serves as a testament to resilience and the relentless pursuit of innovation, even after setbacks.
Overall, as Watt moves forward with Share Ventures, there is optimism for the future as he harnesses technology and personal motivation to foster new developments that could impact many lives.